Korean J Med.
2000 Feb;58(2):152-160.
The study of the shunt index of thallium-201 liver scintigraphy and
liver biopsy in the patients with chronic liver disease
- Affiliations
-
- 1Department of Internal Medicine and Pathology, Hanyang University College of Medicine.
- 2Department of Statistics, Korea University College of Political Science and Economics, Seoul, Korea.
Abstract
-
BACKGROUND: The disturbances of portal circulation in chronic liver disease
may cause hepatic failure, hepatic encephalopathy and variceal bleeding.
The measure of porto-systemic shunt plays a significant role in the management
and prognosis of the patients. So we have evaluated the relationship between
the shunt index of thallium-201 liver scan and the histological grade and
stage of chronic liver disease.
METHODS
The thallium-201 scintigraphy per rectum was evaluated in 159 patients
with chronic liver disease, which were proven with percutaneous liver biopsy.
We used the heart to liver activity ratio at 20 minute as shunt index, representing
portal-systemic shunt. The two pathologists scored independently hepatitis
activity (lobular and porto-periportal activity) and stage (fibrosis).
RESULTS
A significant difference was noted between the shunt index and
the scores of fibrosis (p< 0.001) although this correlation was statistically weak
(r=0.26, p=0.008). In cumulative logistic regression test, the shunt index had
a effect on the fibrosis (p< 0.001) but not on the lobular and porto-periportal
activity. Fibrosis was predicted as less than 2 if shunt index was less than
0.24, 3 if more than 0.24 but less than 0.46, 4 if more than 0.46.
CONCLUSION
The shunt index of thallium-201 liver scintigraphy correlated only
with fibrosis not with lobular and porto-periportal activity. As the fibrosis
progresses in chronic liver disease, portal hypertension becomes more severe
and the shunt index increases. Thallium-201 liver scan may be useful for
evaluation of hepatic fibrosis instead of invasive liver biopsy in predicting
the histological stage (fibrosis) of advanced chronic liver disease.